Replies to post #194 on Options Wonderland

[thewallmaster]

XKEM take a look IMO the next boom check this:

___X__K___E___M_____ biotech up HUGE on

WENT UP AGAINST BRISTOL MYERS AND WON A LAWSUIT ON MAJOR SICKLE CELL
DRUG.

FUNDING BY THE WORLD HEALTH

http://finance.yahoo.com/q?s=XKEM.OB

Dr Pandey and XKEM have done the right thing by working with the
Nigerian FG and other technology groups at SHESTCO
(vitamin C from cassava). They are building a reputation as a
business concerned with the welfare of the Nigerian people. This
should bode well for doing business in the future in Nigeria.
Businesses which have exploited Nigeria's resources without concern
for the people are suffering the consequences of their neglect.

http://allafrica.com/stories/200602240718.html

Nigeria reaches agreement among the various states on resolving its
debt and endorses the National Health Act.

http://allafrica.com/stories/200602240155.html


XKEM ----- Most Recent Press Releases and Financial Statements

XECHEM ANNOUNCES SUCCESSFUL CAPITAL RAISE BY CEPTOR CORPORATION
(XECHEM RECEIVES APPROXIMATELY $1.28 MILLION AS PART OF THE
TRANSACTION)

XECHEM ANNOUNCES SIGNIFICANT PROGRESS IN THE DEVELOPMENT OF ITS
SICKLE CELL DISEASE DRUG (NICOSAN™ / HEMOXIN™)

XECHEM RECEIVES A BROAD U.S. PATENT FOR SECOND GENERATION PACLITAXEL

PROVISIONAL PATENT APPLICATION FILED FOR EPILEPSY COMPOUND C-202 BY
XECHEM'S SUBSIDIARY, CEPTOR CORPORATION

XECHEM Awarded ADDITIONAL European Patent for anti-cancer drug
paclitaxel

XECHEM ANNOUNCES FAVORABLE RULING BY US COURT OF APPEALS IN ITS
antitrust case against Bristol Myers Squibb

XECHEM announces Current Public Filing

XECHEM MAJORITY-OWNED SUBSIDIARY, CEPTOR CORPORATION,
RECEIVES NIH GRANT FOR HEARING LOSS STUDY

Xechem Announces independent financing to ceptor subsidiary

XECHEM announces execution of definitive AGREEMENT documents
regarding business COOPERATION and cash infusion pact WITH alembic,
limited, A major indian pHARMACEUTICAL COMPANY

XECHEM PRESENTS UPDATE ON NIPRISAN – Nix-0699

Xechem and Ceptor Announce Capitalization and financing Plan

Xechem International COMPLETES Ceptor TRANSACTION

Xechem International to Acquire Ceptor Corporation

WILLIAM PURSLEY NAMED PRESIDENT AND CHIEF OPERATING OFFICER OF
XECHEM INTERNATIONAL, INC.

XECHEM RECEIVES PACLITAXEL PATENT

XECHEM RETAINS PHARM-OLAM AND HYMAN, PHELPS AND McNAMARA FOR
HEMOXIN™ IND

Biotech Turnaround Guru, William Pursley, Named Vice-Chairman Of
Xechem International

Xechem Receives Phase I NIH Grant for Treatment of Sickle Cell
Disease with Niprisan -Hemoxin-

Xechem's Sickle Cell Drug, NIPRISAN -HEMOXIN- Granted Orphan Drug
Status by the FDA

XECHEM ANNOUNCES LAUNCH OF NICOSAN™ (formerly "Niprisan")

XECHEM FORMS XECHEM PHARMACEUTICALS NIGERIA LTD.


american bulls buy confirmed for monday

http://www.americanbulls.com/StockPage.asp?
CompanyTicker=XKEM&MarketTicker=OTC&Typ=S


beautiful annotated chart:

http://www.investorshub.com/boards/read_msg.asp?message_id=9875020